EFFECTS OF METFORMIN AND SULFONYLUREA ON EFFICACY AND HYPOGLYCAEMIA WHEN ADDED TO GLARGINE OR NPH INSULIN IN TYPE 2 DIABETES

被引：0
|
作者：
Bretzel, R. G. [1 ]
Traylor, L. [2 ]
Landgraf, W. [3 ]
机构：
[1] Univ Giessen, Dept Med 3, D-35390 Giessen, Germany
[2] Sanofi US Inc, Biostat & Programming, Bridgewater, MA USA
[3] Sanofi, Med Affairs, Frankfurt, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A90 / A90
页数：1
相关论文
共 50 条
  • [1] Effects of Metformin and Sulfonylurea on Efficacy and Hypoglycemia After Addition of Insulin Glargine or NPH in T2DM
    Bretzel, Reinhard
    Traylor, Louise
    Landgraf, Wolfgang
    [J]. DIABETES, 2014, 63 : A237 - A238
  • [2] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
    Dailey, G. E.
    Gao, L.
    Aurand, L.
    Garg, S. K.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
  • [3] Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study
    H. Yki-Järvinen
    R. Kauppinen-Mäkelin
    M. Tiikkainen
    M. Vähätalo
    H. Virtamo
    K. Nikkilä
    T. Tulokas
    S. Hulme
    K. Hardy
    S. McNulty
    J. Hänninen
    H. Levänen
    S. Lahdenperä
    R. Lehtonen
    L. Ryysy
    [J]. Diabetologia, 2006, 49 : 442 - 451
  • [4] Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
    Yki-Järvinen, H
    Kauppinen-Mäkelin, R
    Tiikkainen, M
    Vähätalo, M
    Virtamo, H
    Nikkilä, K
    Tulokas, T
    Hulme, S
    Hardy, K
    McNulty, S
    Hänninen, J
    Levänen, H
    Lahdenperä, S
    Lehtonen, R
    Ryysy, L
    [J]. DIABETOLOGIA, 2006, 49 (03) : 442 - 451
  • [5] An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia
    Fonseca, V.
    Gill, J.
    Zhou, R.
    Leahy, J.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 814 - 822
  • [6] Efficacy of Combination of Insulin Glargine with either Metformin or Sulfonylurea in Patients with Poorly Controlled Type 2 Diabetes
    Chuang, Shih-Ming
    Wang, Chao-Hung
    Liu, Sung-Chen
    Chien, Ming-Nan
    Chen, Wei-Che
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2020, 14 (02) : 138 - 141
  • [7] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
    Dailey, G.
    Aurand, L.
    Garg, S.
    [J]. DIABETOLOGIA, 2011, 54 : S262 - S262
  • [8] Insulin glargine is associated with less hypoglycaemia than NPH insulin in older patients with Type 2 diabetes
    Riddle, M
    Massi-Benedetti, M
    Häring, HU
    Dailey, G
    Murray, F
    Lin, Z
    Rosenstock, J
    [J]. DIABETOLOGIA, 2004, 47 : A328 - A328
  • [9] Efficacy and safety of a fixed dose combination of glimepiride and metformin versus glimepiride when added in to insulin glargine in patients with type 2 diabetes
    Lee, J. -M.
    Lee, J. -H.
    Park, S. -H.
    Kim, S. -J.
    Park, K. -Y.
    Lim, D. -M.
    Chun, S. -W.
    Lee, J. -M.
    Park, K. -S.
    [J]. DIABETOLOGIA, 2011, 54 : S422 - S422
  • [10] Treatment to target in Type 2 diabetes: successful glycaemic control with less nocturnal hypoglycaemia with insulin glargine versus NPH insulin added to oral therapy
    Riddle, M
    Rosenstock, J
    [J]. DIABETOLOGIA, 2002, 45 : A52 - A52
12345